Вопросы современной педиатрии (Jul 2012)

THE ROLE OF THE SOLUBLE TNF-ALPHA RECEPTORS IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS

  • T. M. Bzarova,
  • E. I. Alexeeva,
  • A. N. Fetisova,
  • N. A. Zurikova,
  • S. I. Valieva,
  • R. V. Denisova,
  • E. V. Mitenko,
  • T. V. Sleptsova,
  • K. B. Isaeva,
  • E. G. Chistyakova,
  • N. I. Taibulatov,
  • M. V. Ryazanov,
  • A. V. Anikin,
  • E. I. Zelikovich,
  • G. V. Kurilenkov,
  • E. L. Semikina

DOI
https://doi.org/10.15690/vsp.v11i4.356
Journal volume & issue
Vol. 11, no. 4
pp. 29 – 37

Abstract

Read online

The results of the study of etanercept (soluble tumor necrosis factor alpha receptors) efficacy and safety in treatment of 97 patients with early and late onset of juvenile idiopathic arthritis are demonstrated in this article. The observation period was 12 months. In 48 weeks of anti-TNF treatment the achievement of clinical remission, decrease and normalization of laboratory markers of disease activity, complete restoration of joints function and improvement of life quality was established in 100% of children with early onset and 71% of children with late onset of arthritis. The drug was withdrawn in 13 (14%) patients: in 5 (6%) due to inefficiency, in 3 (4%) — due to development of side effects.

Keywords